Medpace CEO August Troendle disposes of common shares worth $2,894,676.74
MEDP•CEO share sales disclosed
- Medpace: President and CEO August J. Troendle sold 4,673 common shares on Aug. 25-26.
- Sales priced at USD 620.38, USD 620.03; direct holdings fell to 540,544 shares.
- Indirect stake held via Medpace Investors totaled 4.73 million shares.




